Acyclic nucleoside phosphonates in the chemotherapy of DNA virus and retrovirus infections

被引:62
作者
De Clercq, E [1 ]
机构
[1] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
关键词
acyclic nucleoside phosphonates; HPMPC (cidofovir); PMEA (adefovir); PMPA;
D O I
10.1159/000150563
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The acyclic nucleoside phosphonates [HPMPC (cidofovir), PMEA (adefovir) and PMPA] have proved to be effective in vitro (cell culture systems) and in vivo (animal models, clinical studies) against a wide variety of DNA virus and retrovirus infections: i.e., HPMPC against herpesvirus (herpes simplex virus type 1 and 2, varicella-zoster virus, cytomegalovirus, Epstein-Barr virus, human herpesvirus types 6, 7, and 18), polyoma-, papilloma-, adeno-, and poxvirus (vaccinia virus, molluscum contagiosum virus) infections; PMEA against herpesvirus, hepadnavirus (human hepatitis B virus) and retrovirus (human immunodeficiency virus type 1 and 2, simian immunodeficiency virus, and feline immunodeficiency virus) infections; and PMPA against both hepadna- and retrovirus infections.
引用
收藏
页码:295 / 303
页数:9
相关论文
共 67 条
  • [1] Activities of various compounds against murine and primate polyomaviruses
    Andrei, G
    Snoeck, R
    Vandeputte, M
    DeClercq, E
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (03) : 587 - 593
  • [2] Synthesis, in vitro biological evaluation and oral bioavailability of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) prodrugs
    Arimilli, MN
    Kim, CU
    Dougherty, J
    Mulato, A
    Oliyai, R
    Shaw, JP
    Cundy, KC
    Bischofberger, N
    [J]. ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1997, 8 (06) : 557 - 564
  • [3] Kinetic properties of adenine nucleotide analogues against purified 5-phosphoribosyl-1-pyrophosphate synthetases from E-coli, rat liver and human erythrocytes
    Balzarini, J
    Nave, JF
    Becker, MA
    Tatibana, M
    DeClercq, E
    [J]. NUCLEOSIDES & NUCLEOTIDES, 1995, 14 (9-10): : 1861 - 1871
  • [4] Intraocular pressure and aqueous humor dynamics in patients with AIDS treated with intravitreal cidofovir (HPMPC) for cytomegalovirus retinitis
    Banker, AS
    Arevalo, JF
    Munguia, D
    Rahhal, FM
    Ishimoto, B
    Berry, C
    DeClercq, E
    Ochabski, R
    Taskintuna, I
    Freeman, WR
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1997, 124 (02) : 168 - 180
  • [5] Anti-human immunodeficiency virus (HIV) activity, safety, and pharmacokinetics of adefovir dipivoxil (9-[2-(bis-pivaloyloxymethyl)-phosphonylmethoxyethyl]adenine) in HIV-infected patients
    BarditchCrovo, P
    Toole, J
    Hendrix, CW
    Cundy, KC
    Ebeling, D
    Jaffe, HS
    Lietman, PS
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (02) : 406 - 413
  • [6] Blick G, 1997, J ACQ IMMUN DEF SYND, V15, P84
  • [7] BROSGART C, 1997, 37 INT C ANT AG CHEM, P243
  • [8] Cherrington J. M., 1997, International Antiviral News, V5, P91
  • [9] Novel mutation (K70E) in human immunodeficiency virus type 1 reverse transcriptase confers decreased susceptibility to 9-[2-(phosphonomethoxy)ethyl]adenine in vitro
    Cherrington, JM
    Mulato, AS
    Fuller, MD
    Chen, MS
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (09) : 2212 - 2216
  • [10] Susceptibility of human cytomegalovirus to cidofovir is unchanged after limited in vivo exposure to various clinical regimens of drug
    Cherrington, JM
    Miner, R
    Hitchcock, MJM
    Lalezari, JP
    Drew, WL
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (04) : 987 - 992